BharatRohan Achieves Hyperspectral Imaging Milestone for Pharma Quality Screening
Bharatrohan Airborne Innovations Ltd · Press Release · 13 Nov 2026, 1:33 am
BharatRohan Achieves Hyperspectral Imaging Milestone for Pharma Quality Screening BharatRohan Airborne Innovations achieved a technology milestone by applying its proprietary hyperspectral imaging platform to non-destructively detect adulterated and substandard pharmaceutical tablets across visible and near-infrared spectrums. Extending beyond precision agriculture, the company is engaged in exploratory discussions with Indian regulatory and scientific authorities for potential pilot validation. Management estimates an illustrative global TAM of US$0.8–1.8 billion (India TAM: ~US$100–200 million) and a 3-year global SOM of US$1.5–8 million. Further testing across coatings, packaging, and wider formulations remains ongoing.
Original exchange filing (PDF)
More announcements from Bharatrohan Airborne Innovations Ltd
- Earnings Presentation for the Unaudited Financial Results for the Half Year Ended 30th September 2026. · 18 Nov 2026
- Press Release for Unaudited Financial Statement of the Company Half Year ended on 30th September 2026 · 14 Nov 2026
- Intimation of Scheduling Earnings Conference Call for H1 FY27 Financial Results is scheduled on Wednesday i.e 18th November, 2026 · 18 Nov 2026
- Statement of Deviation for Half Year ended 30th September 2026 · 14 Nov 2026
- Approval of Half Year Financial Statement (Standalone and Consolidated) along with Limited Review Report for Half Year Ended 30th September 2026 · 14 Nov 2026
- Board Members in a Board Meeting held on 13th November 2026 to consider and approve the following agendas 1. Consider and Approve Unaudited Financials Results (Standalone and Consolidated) .... · 14 Nov 2026
- BharatRohan INC, a step-down subsidiary of the company, proposes fundraising by way of Private Placement in the USA up to USD 5 million. · 11 Nov 2026
- Bharatrohan Airborne Innovations Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 ,inter alia, to consider and approve Unaudited .... · 13 Nov 2026
